OpiCalc Logo

OpiCalc

989 Clinical Tools

Logo
OpiCalc
ALBI Grade (Liver)ASTCT GradingATA Thyroid RiskBCLC 2022 Staging (HCC)BSA (Mosteller)CLL-IPICML ELTS ScoreCNS-IPICTCAE v5.0Calvert FormulaDIPSS-Plus (Myelofibrosis)Deauville ScoreEAU NMIBC RiskECOG Performance StatusELN 2022 Risk (AML)ELN CML MilestonesFIGO 2021 (Ovarian)FIGO 2023 (Endometrial)FLIPI-2Fleischner 2017 GuidelinesFong Clinical Risk ScoreHCT-CI (Sorror Score)HPV/p16 OropharynxIGCCCG Risk (Testicular)IMDC (Heng) CriteriaIMWG Myeloma FrailtyIPSS-M (Molecular MDS)ISUP Grade GroupsKarnofsky Status (KPS)Khorana ScoreLugano ClassificationLung-RADS v2022MIPI-b (Biological)MRD Assessment FrameworkMSI/MMR InterpretationMayo 20/2/20 (SMM)NCCN Prostate RiskNCCN-IPI (DLBCL)NSCLC GPAOncotype DX RecurrenceOpioid EquianalgesicPD-L1 TPS InterpretationPERCIST 2.0PREDICT v3.0Platinum-Free IntervalR2-ISS (Revised 2)RANO 2.0RCB (Residual Cancer Burden)RECIST 1.1ROMA ScoreSAVER ScoreSINS ScoreSLiM-CRAB CriteriaSedlis/Peters CriteriaTNM 8th (Colorectal)TNM 8th Ed (Prognostic)TNM 9th (Nasopharynx)TNM 9th Ed (NSCLC)TNM 9th Ed (SCLC)Tyrer-Cuzick (IBIS v8)WHO 2021 CNS Class.WHO 2022 / ICC 2022 AMLZ0011 EligibilityiRECISTiwCLL 2018 ResponsemRECIST (HCC)mRENAL ScoremrTRG (Rectal MRI)
OpiCalc Logo

OpiCalc

Open-access clinical infrastructure. Built to the standard every clinician deserves — fast, private, and free.

Zero data stored
Always free
Our mission & transparency

Get in Touch

Tool request, clinical feedback, or partnership inquiry — we read everything.

WhatsApp feedback
Email us
Partnership inquiry

© 2026 OpiCalc • Calculated Care

ProtocolsAboutPrivacyTerms

PREDICT v3.0

Breast Cancer

Interpreter for official PREDICT v3 overall survival and treatment benefit outputs.

Calculated Interpretation

Minimal Benefit

PREDICT v3 outputs should be interpreted as absolute benefit estimates, not standalone treatment decisions.

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Primary Use

Interpreter for official PREDICT v3 overall survival and treatment benefit outputs.
Section 2

Formula & Logic

Clinical Inputs

Estimated absolute systemic-therapy benefitCategorical selection
Section 3

Pearls/Pitfalls

Result Bands

Section 4

Next Steps

Suggested Next Steps

01
Interpret the result in the full disease-specific clinical context.
02
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.
Section 5

Evidence Appraisal

Evidence Base

Interpreter for official PREDICT v3 overall survival and treatment benefit outputs.

OpiCalc Medical Oncology Module • Breast Cancer. 2026;Logic implemented from widely used contemporary oncology classification, prognostic, and response-assessment frameworks.

Section 6

Literature

Context

PREDICT v3.0 is included in the oncology module as a structured decision-support tool for breast cancer workflows.

Last Comprehensive Review: 2026

Related Oncology Tools

CNS-IPI
FLIPI-2
R2-ISS
IMWG Myeloma Frailty
SLiM-CRAB Criteria
Mayo 20/2/20
DIPSS-Plus
HCT-CI
TNM 9th Ed
TNM 9th Ed
Have feedback about this calculator?Let us know.